Researchers found that a new oral solution called Tessie® has been approved by the FDA for treating anxiety and fear in dogs. This product, which contains the active ingredient tasipimidiini, aims to help pets cope with stressors like loud noises and separation from their owners. As pet owners become increasingly aware of their furry friends’ mental health, this approval offers a new option for those looking to improve their pets’ well-being.

This development matters for dog owners who want to ensure their pets are happy and healthy. Anxiety in dogs can lead to destructive behaviors, poor health, and a strained relationship with their owners. With Tessie®, which is expected to be available in the U.S. by mid-2027, dog owners will have a scientifically-backed solution to help their pets manage anxiety, potentially improving their quality of life and strengthening the bond between them.

The evidence supporting Tessie® comes from its approval process by the FDA, indicating that it has undergone necessary evaluations for safety and efficacy. However, it’s essential to note that the product is still in the early stages of its market introduction, and more data on its long-term effects and effectiveness in various dog breeds will be valuable as it becomes available.

If you’re a dog owner concerned about your pet’s anxiety, consider discussing this new option with your veterinarian when it becomes available. They can provide guidance on whether Tessie® might be a suitable choice for your dog’s specific needs, along with other strategies for managing anxiety.

Source: globenewswire.com